|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense), net: | ||
| Share-based compensation expense | ||
| Interest earned on bank deposits | ||
| Interest earned on marketable securities held in Trust Account | ||
| Interest income | ||
| Income from transition services agreements | ||
| Change in fair value of participation right liability | ||
| Other income (expense) | ||
| Total other income (expense), net | ||
| Net loss | ||
| Net loss per share attributable to common stockholders, basic | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total net loss per share attributable to common stockholders, basic | ||
| Net loss per share attributable to common stockholders, diluted | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total net loss per share attributable to common stockholders, diluted | ||
| Weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total weighted-average number of shares used in computing net loss per share attributable to common stockholders, basic | ||
| Weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted | ||
| Class A Ordinary Shares | ||
| Class B Ordinary Shares | ||
| Total weighted-average number of shares used in computing net loss per share attributable to common stockholders, diluted |
Loading...
